patients undergoing percutaneous

Related by string. * PATIENTS . PATIENT . Patients : Breast Cancer Patients . terminally ill patients . Patient Safety / UNDERGOING . Undergo . Undergoing : undergo psychiatric evaluation . undergoing psychiatric evaluation . undergo arthroscopic surgery / Percutaneous : percutaneous coronary intervention . percutaneous transluminal coronary angioplasty . percutaneous transluminal angioplasty * *

Related by context. All words. (Click for frequent words.) 73 primary percutaneous coronary 73 coronary intervention 73 undergoing percutaneous coronary 71 non valvular atrial 71 ARIXTRA 70 undergo percutaneous coronary 69 aspirin clopidogrel 69 atherothrombotic events 69 coronary interventions 69 myocardial infarction ventricular fibrillation 69 unstable angina UA 69 Thrombolysis 69 Carotid Revascularization Endarterectomy vs. 68 angioplasty stenting 68 Percutaneous Transluminal Coronary Angioplasty 68 acute coronary syndromes ACS 68 glycoprotein IIb IIIa inhibitors 68 Percutaneous Coronary Intervention 68 ACTEMRA TM 68 heparin induced thrombocytopenia 68 antiplatelet drugs 68 thromboembolic complications 67 coronary revascularization 67 percutaneous transluminal coronary angioplasty 67 patients undergoing CABG 67 IIIa inhibitor 67 NAVISTAR R 67 underwent percutaneous coronary 67 antiarrhythmic drug 67 aspirin heparin 67 induced macular edema 67 PLX STROKE targeting 67 undergoing elective percutaneous 67 transluminal coronary angioplasty PTCA 67 treating abdominal aortic 67 antiplatelet medications 67 candesartan cilexetil 67 aldosterone antagonists 67 prostate TURP 66 carotid artery stenting 66 myelodysplastic myeloproliferative diseases 66 Chronic Heart Failure 66 stable angina pectoris 66 NATRECOR R 66 Endologix Powerlink System 66 hypervascular tumors 66 NATRECOR ® 66 percutaneous coronary interventions 66 lipid lowering agents 66 β blockers 66 vapreotide acetate 66 coronary stenting 66 cilostazol 66 Erythropoietic therapies may 66 catheter occlusion 66 purpura ITP 66 deep venous thromboses 66 Sirolimus eluting Coronary Stent 66 undergoing coronary artery 66 chronic immune thrombocytopenic 66 clopidogrel Plavix 66 antiplatelet agents 66 pain palliation 66 brand ciclesonide HFA 66 endoluminal stent graft ELG 66 recurrent glioblastoma multiforme 65 ischemic complications 65 ARCOXIA 65 GP IIb IIIa inhibitors 65 VIIBRYD 65 Stent System 65 Adjunctive 65 TAXUS Express Stent 65 symptomatic BPH 65 Coronary Artery Bypass Graft 65 acute myocardial infarction AMI 65 surgical revascularization 65 Ranolazine 65 Angiox R 65 hyperphenylalaninemia HPA due 65 CYT# potent vascular disrupting 65 non splenectomized 65 dyslipidemia hypertension diabetes 65 XIENCE V PROMUS Stent 65 TAXUS TM 65 symptomatic hyponatremia 65 NYHA Class II 65 Bare Metal Stent 65 thetreatment 65 primary hypercholesterolemia 65 Abciximab 65 relapsing remitting MS RRMS 65 V Everolimus Eluting Coronary 65 paroxetine Paxil 65 paclitaxel eluting stents 65 recombinant tissue plasminogen 65 rFVIIa 65 stent DES 65 anticoagulant warfarin 65 glycoprotein IIb IIIa inhibitor 65 stable angina 65 CYPHER R Sirolimus eluting 65 Dementia Related Psychosis 65 rheumatoid arthritis osteoarthritis ankylosing 65 Dabigatran 65 J Am Coll 65 endoluminal stent graft 65 multivessel disease 65 surgical aortic valve 65 Mg Usa 65 descending thoracic 65 multicenter Phase III 65 ischemic cardiomyopathy 65 aripiprazole Abilify 65 HMG CoA reductase inhibitors 65 hepatic metastases 65 PROMUS Element Stent 65 IMiDs ® compound 65 Myocardial Infarction Study 65 anti arrhythmic drug 65 erlotinib Tarceva ® 65 PEGINTRON TM 65 containing granisetron 65 venous thromboembolisms 65 reteplase 64 Accelerated Partial Breast Irradiation 64 anticlotting drugs 64 INVANZ 64 angiotensin receptor blocker ARB 64 chronic thromboembolic pulmonary 64 prokinetic agent 64 percutaneous interventions 64 chronic idiopathic thrombocytopenic purpura 64 thrombolytic agent 64 Combination therapy 64 ACE inhibitors beta blockers 64 postoperative atrial fibrillation 64 refractory angina 64 acute STEMI 64 recurrent DVT 64 Helicobacter pylori eradication 64 CoreValve System 64 metastatic malignant 64 aneurysms AAA 64 venous thromboembolic events 64 dalteparin 64 Acute Myocardial Infarction 64 NSTE ACS 64 TAXUS Liberte Long 64 fully bioabsorbable 64 adalimumab Humira 64 oral rivaroxaban 64 beclomethasone dipropionate 64 Prospective Randomized 64 workhorse lesions 64 coronary artery bypass grafts 64 antiarrhythmic drugs 64 rosuvastatin Crestor 64 Kit CD# positive 64 thiazide diuretic 64 cardiac resynchronisation therapy 64 CYPHER Stent 64 severe renal impairment 64 fondaparinux sodium 64 antithrombotic therapy 64 PREZISTA r 64 ATACAND 64 colorectal adenoma 64 nicardipine 64 Pivotal Trial 64 death dissection perforation 64 transarterial 64 paclitaxel eluting stent 64 tumor lysis syndrome 64 peripheral artery 64 occlusive disease 64 complement inhibitor eculizumab 64 angioplasties stents 64 invasive candidiasis 64 elective percutaneous coronary 64 trials RCTs 64 psoriatic arthritis PsA 64 Warfarin Coumadin 64 venous thromboembolic disease 64 infarction NSTEMI 64 thrombolytic therapy 64 severe hypercholesterolemia 64 prophylactic therapy 64 acute coronary syndromes 64 Eluting Coronary Stent System 64 RoACTEMRA 64 receiving prophylactic anticoagulation 64 aldosterone antagonist 63 direct thrombin inhibitors 63 oral antidiabetic medication 63 fibrinolytic therapy 63 rheumatoid arthritis psoriatic arthritis 63 placebo controlled Phase III 63 TAXUS Liberte Stent 63 arterial thrombosis 63 unresectable recurrent 63 thrombus aspiration 63 sorafenib tablets 63 systemic embolism 63 valsartan amlodipine 63 TYGACIL 63 SilverHawk Plaque Excision System 63 xanthine oxidase inhibitor 63 TAXUS Element Paclitaxel Eluting 63 infliximab Remicade 63 antihypertensive agents 63 direct thrombin inhibitor 63 recurrent VTE 63 Keppra R 63 Intravitreal injections 63 thromboprophylaxis 63 tenecteplase 63 retinal vein occlusion induced 63 unresectable HCC 63 carotid artery stenting CAS 63 transthoracic 63 Wafer polifeprosan 63 Methylnaltrexone 63 6R BH4 63 percutaneous coronary intervention 63 symptomatic intracranial 63 PROMUS R 63 Peginterferon alfa 2b 63 coronary stent merged 63 carotid stent 63 stage IIIb IV 63 antiplatelet agent 63 chronic myocardial ischemia 63 Intensive blood glucose 63 Telmisartan 63 MAGE A3 ASCI 63 visilizumab 63 DU #b 63 eluting stent 63 INVEGA ® 63 undergone radical prostatectomy 63 herpetic keratitis 63 reinfarction 63 long acting bronchodilator 63 postoperative AF 63 intra arterial 63 carotid endarterectomy CEA 63 sirolimus eluting 63 plus GP IIb 63 hepatorenal syndrome 63 relapsed refractory multiple myeloma 63 Hydroxyurea 63 symptomatic VTE 63 ST Segment Elevation 63 invasive aspergillosis 63 ALN HPN 63 Spectranetics laser 63 FRAGMIN 63 GORE VIABAHN Endoprosthesis 63 bifurcated lesions 63 beta blockers ACE inhibitors 63 chronic ITP patients 63 reduce serum phosphate 63 revascularization procedures 63 unstable angina pectoris 63 ß blockers 63 osteoarthritis rheumatoid arthritis 63 REVLIMID lenalidomide 63 replacement TAVR 63 acute ischemic stroke 63 carotid surgery 63 oropharyngeal candidiasis OPC 63 Mitomycin C 63 Unstable Angina 63 pioglitazone HCl 63 chronic eosinophilic leukemia 63 XIENCE V vs. 63 TAXUS ® 63 Patients Treated With 63 intravesical therapy 63 Events MACE 63 XIENCE V demonstrated 63 BENICAR HCT 63 label multicenter 63 Coronary stents 63 either acutely decompensated 63 hypercholesterolaemia 63 thromboembolic events 63 XIENCE V Everolimus Eluting 63 cinacalcet 63 CABG surgeries 63 noninvasive outpatient 63 MULTAQ 63 thoracoscopic lobectomy 63 Fractional Flow Reserve 63 ST elevation myocardial 63 angiotensin converting enzyme inhibitors 63 metformin sulfonylurea 63 acute coronary syndrome 63 coronary revascularization procedures 63 Serostim ® 63 inferior vena cava filters 63 radiofrequency RF ablation 63 INSPIRE Trial Phase III 63 relapsed MM 63 abacavir lamivudine 63 Taxus Stent 63 TNF Tumor Necrosis Factor 63 revascularisation 63 castrate resistant prostate cancer 63 novel VDA molecule 63 docetaxel Taxotere ® 63 TAXUS Liberte stent 62 recurrent metastatic 62 drug zotarolimus 62 Drug Eluting Stent System 62 thrombotic events 62 methylnaltrexone bromide 62 Complicated Skin 62 AVAPRO 62 vitreoretinal disorders 62 Angiomax ® 62 platelet inhibitor 62 oral FTY# 62 Vidaza azacitidine 62 NSAID induced 62 left ventricular dysfunction 62 KRAS mutations occur 62 COMBIVIR 62 dasatinib Sprycel ® 62 interferon alfa 2b 62 pharmacologic stress agent 62 carbamazepine phenobarbital phenytoin rifampin 62 valvular disease 62 metastatic GIST 62 peripheral arterial occlusive disease 62 mycophenolate mofetil 62 mcg QD 62 transplantation HCT 62 onset atrial fibrillation 62 Clolar ® 62 posaconazole 62 coronary revascularisation 62 metastatic dermatofibrosarcoma protuberans DFSP 62 Guideline Update 62 raloxifene Evista 62 Cypher Sirolimus 62 CYPHER ® Stent 62 rosuvastatin #mg 62 multicenter randomized 62 serum phosphorous 62 biologic DMARD 62 Hycamtin ® 62 chronic HCV infection 62 potent CYP#A# inhibitors 62 Intravitreal 62 adult chronic ITP 62 oral dual endothelin 62 deCODE AF TM 62 liver resection surgeries 62 endocrine therapies 62 GORE TAG Device 62 Everolimus Eluting Coronary Stent 62 transurethral resection 62 vaginally administered lidocaine 62 nucleotide analogue 62 systemic immunosuppressive drugs 62 PEG INTRON R 62 colorectal liver metastases 62 morphometric vertebral fractures 62 NYHA Class III 62 thromboembolic 62 treatment naïve genotype 62 aspirin beta blockers 62 sirolimus eluting stents 62 Stenting Trial CREST 62 drotrecogin alfa activated 62 stenoses 62 VTE prophylaxis 62 Losartan 62 DG# compounds targeting 62 undergoing angioplasty 62 INTEGRILIN R 62 worsening thrombocytopenia 62 venous thromboembolism VTE prophylaxis 62 hydroxymethyl coenzyme 62 ACE Inhibitors 62 Nesiritide 62 diabetic gastroparesis 62 defibrillator CRT D 62 reversing heparin 62 WallFlex Biliary RX 62 somatostatin analogue 62 PEGylated anti 62 Angiographic 62 albiglutide 62 composite endpoint 62 saphenous vein grafts 62 TAXUS Stent 62 carotid endarterectomy 62 BCR ABL inhibitor 62 hyperplasia BPH 62 Lubiprostone 62 nonrandomized 62 Moxifloxacin 62 Acute Coronary Syndrome 62 TRANSDUR ® 62 Renal Impairment 62 receiving VELCADE 62 BCG refractory carcinoma 62 severe oral mucositis 62 oral anticoagulant 62 Coronary Stent 62 PCI percutaneous coronary 62 EURIDIS 62 serotonin norepinephrine reuptake inhibitor 62 placebo controlled clinical 62 repeat revascularization 62 angina myocardial infarction 62 flutamide 62 pulmonary artery banding 62 risperidone Risperdal 62 FRAGMIN R 62 active comparator 62 ® lenalidomide 62 Taxus Element 62 subependymal giant cell 62 kidney urologic 62 transcatheter closure 62 FASLODEX 62 abdominal aortic aneurysms AAA 62 Perforomist ™ Inhalation Solution 62 mg QD 62 unresectable liver cancer 62 QUADRAMET R 62 Carotid artery stenting 62 immune idiopathic thrombocytopenic 62 cerebrovascular events 62 Fondaparinux 62 ramipril Altace 62 Clinical Trial Evaluating 62 saphenous vein graft 62 bypass grafting 62 AGILECT R 62 TAXUS p value 62 Tocilizumab 62 Navelbine ® 62 dihydroergotamine DHE 62 Acute Coronary Syndromes 62 NeuroStar TMS Therapy 62 Cordis Cypher 62 pegylated alpha interferon 62 TAXUS Liberte 62 MACCE 62 pegylated interferon alfa 62 Mg Uk 62 primidone 62 repair TEVAR 62 papillary renal cell carcinoma 62 Severe Sepsis 62 endarterectomy 62 carotid artery blockage 62 intracerebral hemorrhage ICH 62 inhibit platelet function 62 carotid stenting 62 tirofiban 62 rufinamide 62 noncardiac surgery 62 bivalirudin 62 TREDAPTIVE 62 ticlopidine 62 lumiracoxib 62 bone marrow reticulin deposition 62 controlled multicenter 62 Syncria R 62 prospective multicenter study 62 salmeterol fluticasone 62 bi ventricular pacing 62 thrombolytics 62 RE LY ® 62 receiving INTRON 62 Randomized Evaluation 62 BoNTA 62 alfa 2a 62 INCB# [003] 62 lucinactant 61 acetonide FA 61 QVAR R 61 Certolizumab pegol 61 DAPT 61 opioid induced constipation OIC 61 ACE inhibitor ramipril 61 liver resection 61 Pemetrexed 61 thromboembolisms 61 aplastic anemia AA 61 TNF antagonists 61 Achieves Primary Endpoint 61 angiotensin converting enzyme inhibitor 61 pericardial effusion 61 myocardial infarction MI 61 Cardiol 61 virus HCV protease inhibitor 61 failure ADHF 61 evaluating picoplatin 61 LEVAQUIN ® 61 decompensated heart failure 61 CTO recanalization 61 sorafenib Nexavar 61 unfractionated heparin UFH 61 intracranial atherosclerosis 61 sirolimus stent 61 anticoagulation therapy 61 lenalidomide Revlimid R 61 inguinal hernia repair 61 interferon ribavirin 61 endometriosis ovarian cysts 61 thoracic aortic aneurysms 61 macrolide antibiotic 61 phase III isavuconazole 61 urethral bulking agent 61 treat menorrhagia 61 toenail onychomycosis 61 ExTRACT TIMI 61 BENICAR 61 Liberte TM 61 drug eluting stent implantation 61 de novo kidney transplant 61 Express2 TM paclitaxel eluting 61 acute peripheral arterial 61 lipid lowering drugs 61 ADP receptor antagonist 61 refractory chronic lymphocytic 61 EnteroMedics proprietary neuroblocking technology 61 hemodialysis patients 61 Val HeFT 61 LEUKINE 61 oral anticoagulation 61 CABG surgery 61 Benign Prostatic Hyperplasia BPH 61 evaluating REVLIMID 61 GnRH agonist 61 calcineurin inhibitor 61 immunosuppressive regimen 61 superficial femoral 61 thrombectomy 61 Valcyte tablets 61 active ankylosing spondylitis 61 chronic ITP 61 Pivotal Clinical Trial 61 included exfoliative dermatitis 61 Tasigna prolongs 61 alteplase 61 haloperidol Haldol 61 #mg BID [001] 61 Cotavance 61 metformin sulphonylurea 61 hypokalemia hypomagnesemia 61 underwent CABG 61 gefitinib Iressa 61 ribavirin RBV 61 interferon beta 1a infertility 61 HCV NS5B polymerase 61 rt PA 61 topiramate Topamax 61 CTAP# Capsules 61 atherosclerotic renal artery stenosis 61 memantine HCl 61 acute myocardial infarctions 61 ALVESCO R 61 thrombolytic agents 61 MIRAPEX 61 certolizumab 61 idraparinux 61 Angiox ® 61 irregular quivering 61 tamoxifen Nolvadex ® 61 Intra arterial 61 GRNCM1 61 Naive Patients 61 refractory ischemia 61 TAXUS Express2 61 cardiometabolic diseases Glucophage 61 Lenalidomide 61 GEM OS2 61 transcatheter aortic valve implantation 61 CHAMPION PCI 61 Vascugel ® 61 Ischemic 61 Traficet EN 61 Cardiac Resynchronization Therapy 61 H2 receptor antagonists 61 functional mitral regurgitation 61 PEGylated interferon beta 1a 61 ™ Paclitaxel Eluting 61 cardiopulmonary bypass CPB 61 hypertrichosis occurred 61 cutaneous T 61 neoadjuvant 61 atypical Hemolytic Uremic Syndrome 61 familial amyloidotic polyneuropathy FAP 61 mild vasodilator 61 sunitinib malate 61 Nilotinib 61 MIST II 61 ischemia driven 61 APTIVUS ritonavir 61 terlipressin 61 stage IIIB 61 immunomodulatory therapy 61 FluCAM arm 61 TORISEL 61 Embolic Protection Device 61 irbesartan 61 VELCADE melphalan 61 romiplostim 61 bendamustine 61 lexidronam injection 61 Percutaneous Coronary Interventions 61 headache nasopharyngitis 61 SinuNase TM 61 STEMI patients 61 neurogenic bladder 61 Altera Nebulizer System 61 Teriflunomide 61 undergoing coronary angiography 61 refractory recurrent 61 adjunctively 61 somatostatin analog 61 salmeterol inhalation powder 61 Endovascular System 61 anthracycline taxane 61 Vimpat R 61 ARIXTRA R 61 chronic angina 61 glucocorticoid induced osteoporosis 61 thrombotic complications 61 AVASTIN 61 paroxysmal AF 61 AA Amyloidosis 61 pregabalin Lyrica 61 arteriovenous malformations 61 MYCAMINE 61 noninferior 61 mcg kg REBETOL 61 Pioglitazone 61 Acute Coronary Syndromes ACS 61 TAXUS Element Stent System 61 Nonsurgical 61 Patients Undergoing 61 fluvastatin 61 Peripheral artery disease 61 cardiogenic shock 61 Severe VOD 61 metformin HCl 61 superficial basal cell carcinomas 61 arteriovenous access 61 fallopian tube cancers 61 tiuxetan 61 reflux disease GERD 61 clozapine Clozaril 61 Natalizumab 61 carotid stents 61 Certican 61 FOLOTYN ® 61 thromboembolic disease 61 Coronary artery bypass grafting 61 ZOLINZA 61 peritumoral brain edema 61 investigational antiplatelet agent 61 Atom Stent 61 CARE HF 61 HoFH 61 BRIM2 61 Cleviprex TM clevidipine 61 Vidaza ® 61 Genous stent 61 Vascular Closure Device 61 GTC recombinant human 61 BCG refractory 61 Rivaroxaban 61 distal embolization thrombus formation 61 aliskiren amlodipine 61 recurrent malignant glioma 61 upper gastrointestinal bleeding 61 coronary carotid 61 systemic juvenile idiopathic 61 superficial bladder cancer 61 Rilonacept 61 Percutaneous vertebroplasty 61 evaluate ZFP Therapeutic 61 Nitinol Stent 61 icatibant 61 mixed hyperlipidemia 61 ALVESCO ® 61 R Saizen R 61 CTEPH 61 dihydroergotamine 61 TAXUS Stents 61 asymptomatic hyperuricemia 61 idursulfase 61 LHRH receptor positive 61 undergoing coronary angioplasty 61 Doxil ® 61 CYPHER R Sirolimus Eluting 61 idiopathic thrombocytopenic purpura ITP 61 pravastatin Pravachol 61 antiplatelet medication 61 PegIntron 61 minimally invasive interventional 61 everolimus tablets 61 thienopyridines 61 everolimus eluting stents 61 ADL# novel 61 Vascugel 61 Coadministration 61 XIENCE V stent 61 catheter angiography 61 KETEK 61 ocular hypertension 61 R lenalidomide 61 R bisoprolol Euthyrox 61 left ventricular systolic 61 TAXUS stent 61 vinorelbine tartrate 61 PRADAXA 61 ribavirin therapy 61 bevacizumab Avastin ® 61 Express2 61 HCV RESPOND 2 61 minimally symptomatic 61 multicenter Phase II 61 hypereosinophilic syndrome 61 Renal dysfunction 61 vWD 61 antiepileptics 61 known sulfonamide allergy 61 Acute Myocardial Infarction AMI 61 inotropes 61 video assisted thoracoscopic 61 esophagogastric 61 nonsteroidal antiinflammatory drugs 61 Microplasmin 61 Endeavor Drug Eluting 61 By JENNIFER LEARN 61 Transcatheter aortic valve implantation 61 systemic hypotension 61 symptomatic uterine fibroids 61 metastatic renal cell carcinoma 61 non squamous NSCLC 61 designated HVTN 61 Paraplatin ® 61 PICSO ® 61 relapsing multiple sclerosis 61 β blocker 61 infusional 5-FU/LV 60 ReoPro 60 PFO closure 60 receptor tyrosine kinase inhibitor 60 Celebrex celecoxib 60 prospective randomized multicenter 60 basiliximab 60 Oral Fingolimod 60 treat brain aneurysms 60 CellCept mycophenolate mofetil 60 Pulmonary Embolism PE 60 Coronary artery bypass graft 60 gastro esophageal reflux disease 60 cIAI 60 monoclonal antibody IgG1 Mab 60 nondiabetic patients 60 Bucindolol 60 myocardial perfusion imaging 60 hereditary antithrombin deficient 60 NOXAFIL 60 receiving chemoradiation therapy 60 deferiprone 60 systemic fungal infections 60 retinopathy nephropathy 60 cisplatin gemcitabine 60 intravesical infusion therapy 60 MGd 60 IXEMPRA 60 LNG IUS 60 eplerenone 60 Pegasys ® 60 elective PCI 60 CIMZIA TM certolizumab pegol 60 chemoembolization 60 IONSYS TM 60 symptomatic paroxysmal AF 60 thiazolidinediones TZDs 60 Cilostazol 60 investigational pharmacologically unique 60 ORENCIA ® 60 chemoradiation therapy 60 anakinra 60 FDA APPROVES 60 Foradil Aerolizer 60 quetiapine Seroquel 60 Amrubicin 60 gastrointestinal GI motility disorders 60 Edge STudy 60 Anti Bacterial Envelope 60 observational cohort 60 metastatic neuroendocrine tumors 60 DEXILANT 60 ziprasidone Geodon 60 keloid scarring 60 colesevelam HCl 60 concomitant medications 60 IV tPA 60 PROMUS TM 60 Mycophenolate Mofetil 60 MEND CABG 60 ergot derivatives 60 occlusive atherosclerotic disease 60 inhaled bronchodilators 60 lintuzumab SGN 60 severe aortic stenosis 60 unresectable tumors 60 pediatric malignancies 60 dexamethasone Decadron 60 DOXIL 60 HES CEL 60 REMINYL ® 60 de novo lesions 60 Surgical resection 60 IMiDs 60 interferon gamma 1b 60 2 diabetes UKPDS 60 advanced metastatic renal 60 ThermoDox R 60 alfuzosin 60 Implantable cardioverter defibrillators 60 LMWH 60 etanercept Enbrel 60 Chronic Idiopathic Constipation 60 octreotide LAR 60 anastomotic devices 60 dirucotide MBP# 60 FOLFOX6 chemotherapy regimen 60 vertebral compression fractures 60 carisbamate 60 budesonide pMDI 60 AIR CF1 60 plus prednisone 60 fibrillation AF 60 meropenem 60 RISPERDAL ® 60 FUSILEV enhances 60 psoriasis vulgaris 60 Endoprosthesis 60 gastrointestinal disorders ATI 60 hoFH 60 acyclovir Lauriad R 60 occlusion PAO 60 infarction STEMI 60 evaluating tivozanib 60 five MDS subtypes 60 severe exacerbations 60 TAVR 60 candidates Azedra TM 60 zolmitriptan 60 Primary Hypercholesterolemia 60 reblockage 60 recurrent GBM 60 IMiDs ® 60 Heparin Bioactive Surface 60 haematologic 60 thoracic aortic 60 ADHF 60 essential thrombocythemia ET 60 Restenosis 60 primary generalized tonic 60 SYNERGY Stent 60 endovascular stent graft 60 CYP#A# CYP#D# 60 gynecologic procedures 60 atherothrombotic disease 60 riociguat 60 unfractionated heparin 60 prospective multicentre 60 CLINICAL STUDIES 60 investigational immunotherapy 60 binary restenosis 60 Known hypersensitivity 60 HCV SPRINT 60 endometrial hyperplasia 60 develop HBV reactivation 60 STRIDE PD 60 Endovascular Valve Edge 60 sunitinib Sutent 60 Folfox 60 overactive bladder syndrome 60 metastatic HRPC 60 decompensated liver disease 60 hemodynamically significant 60 systolic hypertension 60 opioid induced bowel dysfunction 60 microvascular disease 60 Drug eluting stent 60 Inhalation Aerosol 60 acarbose 60 Lambert Eaton Myasthenic 60 SORT OUT III 60 diuretics beta blockers 60 Ecallantide 60 Starlix 60 Platinol ® 60 Bivalirudin 60 carotid artery disease 60 comparing XIENCE V 60 atrial arrhythmias 60 thrombin inhibiting aptamer 60 OPCAB 60 gemcitabine Gemzar 60 Tolvaptan 60 pediatric Crohn disease 60 tolvaptan 60 acetylcholinesterase inhibitor 60 Pivotal Phase III 60 cardiovascular hospitalizations 60 esophageal candidiasis 60 angiotensin receptor blockers ARBs 60 ximelagatran 60 dose dose escalation 60 Infusion Reactions Severe 60 Camptosar ® 60 Renal Artery 60 coronary arteriography 60 occlusion CRVO 60 cyclosporine tacrolimus 60 rALLy clinical trial 60 Carotid 60 bypass graft CABG surgery 60 CIMZIA ™ 60 carotid artery stent 60 serologically active systemic lupus 60 myocardial infarctions 60 percutaneous intervention 60 coronary blockages 60 GnRH agonists 60 angina pectoris 60 Catheter ablation 60 prescribed atypical antipsychotic 60 TNF antagonist 60 See WARNINGS 60 MADIT II 60 Arch Intern Med 60 PROMUS ® 60 benign prostatic hypertrophy BPH 60 protease inhibitor PI 60 Statin therapy 60 administered concomitantly 60 esophageal gastric 60 Torisel 60 REVIVE Diabetes 60 milrinone 60 Cardiac Resynchronization 60 angiographic outcomes 60 ribavirin USP 60 liposomal doxorubicin 60 Enhanced External Counterpulsation 60 Entereg R 60 liposomal formulation 60 inhaled budesonide 60 angiotensin II receptor blockers 60 ZYVOX 60 histone deacetylase HDAC inhibitor 60 coronary artery bypass grafting 60 Noxafil 60 antidiabetic drugs 60 hereditary deficiency 60 pulmonary embolism PE 60 Dabigatran etexilate 60 peginterferon alfa 2a Pegasys 60 Xelox 60 reslizumab 60 Octreolin 60 rhIGF-I/rhIGFBP-3 60 Chronic HCV 60 vinca alkaloid 60 splenectomized 60 onset diabetes mellitus 60 Hepatocellular Carcinoma HCC 60 segment elevation myocardial 60 Cardiac resynchronization therapy 60 intracerebral hemorrhage 60 constipation OIC 60 Ranibizumab 60 systemic corticosteroid 60 randomized multicenter trial 60 APPRAISE 60 Randomized Double Blind 60 Hsp# Inhibitor 60 NNT = 60 fallopian tube carcinoma 60 CLARITY TIMI

Back to home page